n'-(2-Chloroacetyl)-4-fluorobenzohydrazide, 95%, 1g

2?,3?,5?,6?-Tetrahydrospiro[2H-1-benzopyran-2,4?-[4H]pyran]-4(3H)-one, 98%, 1g

12-Crown 4-Ether>95.0%(GC)5mL

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 97%, 10g

2,3-DIHYDROBENZO[1,4]DIOXINE-5-CARBOXYLIC ACID(PIPERIDIN-4-YLMETHYL)AMIDE HCL, 95.0%, 10g

2-propanolo, minimo 99,5%, per sintesi, 10 l, confezione in plastica.

6,7-Dimethoxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, 95%, 1g

TERT-BUTYL 3-THIA-6-AZABICYCLO[3.1.1]HEPTANE-6-CARBOXYLATE, 95.0%, 1g

5-Bromo-6-fluoropyridin-3-amine, 95.0%, 25g

4-(but-3-yn-1-yloxy)-2-hydrazinyl-6-methylpyrimidine, 95.0%, 500mg

8,8-DIFLUORO-3-AZABICYCLO[3.2.1]OCTANE HCL, 95.0%, 100mg

2-(4-Chloro-3,5-dimethyl-phenoxy)-propionic acid, 95.0%, 1g

nitro-Grela>97.0%(HPLC)500mg